Stock listing

Captor Therapeutics Sa

Selected listing: A3CNAX · LSX · EUR · DE

Captor Therapeutics Sa (LS Exchange: A3CNAX), Health Technology. Latest release May 30, 2023: Captor Therapeutics Publishes Q1 2023 Financial Results.

A3CNAX:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: A3CNAX
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LS Exchange
Currency: EUR

About Captor Therapeutics Sa

The company focuses on developing innovative therapeutic solutions. Its commitment to advancing healthcare is reflected in its ongoing research and development efforts.

Latest news from Captor Therapeutics Sa

Captor Therapeutics Publishes Q1 2023 Financial Results

May 30, 2023

Captor Therapeutics Announces Three-Year Strategic Objectives

March 7, 2023

Captor Therapeutics Reports Q3 2022 Results and Provides Business Update

November 25, 2022

Ono Pharmaceutical and Captor Therapeutics Announce Drug Discovery Collaboration to Develop Small Molecule Protein Degraders for the Treatment of Neurodegenerative Diseases

November 14, 2022

Captor Therapeutics Nominates the Molecular Glue CPT-6281 as Drug Candidate to Enter CTA/IND-Enabling Studies for the Treatment of Hepatocellular Carcinoma

August 10, 2022

All Captor Therapeutics Sa news →

Research Captor Therapeutics Sa

Captor Therapeutics Sa company profile

View the public company page for Captor Therapeutics Sa on 6ix.

Captor Therapeutics Sa news

Read company news and market updates connected to Captor Therapeutics Sa.

Captor Therapeutics Sa investor events

Find investor webinars, events, and replay context for Captor Therapeutics Sa.